Osman Güner

2.2k total citations · 1 hit paper
36 papers, 1.6k citations indexed

About

Osman Güner is a scholar working on Computational Theory and Mathematics, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Osman Güner has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Computational Theory and Mathematics, 9 papers in Organic Chemistry and 8 papers in Molecular Biology. Recurrent topics in Osman Güner's work include Computational Drug Discovery Methods (12 papers), Advanced Chemical Physics Studies (6 papers) and Chemical Synthesis and Analysis (4 papers). Osman Güner is often cited by papers focused on Computational Drug Discovery Methods (12 papers), Advanced Chemical Physics Studies (6 papers) and Chemical Synthesis and Analysis (4 papers). Osman Güner collaborates with scholars based in United States, Türkiye and United Kingdom. Osman Güner's co-authors include Yasuhisa Kurogi, J. Phillip Bowen, Koop Lammertsma, Omoshile Clement, Diane F. Matesic, Raphael M. Ottenbrite, Peter V. Alston, Donald D. Shillady, Robert S. Phillips and Jonathan P. Bowen and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Chemical Physics and The Journal of Physical Chemistry.

In The Last Decade

Osman Güner

35 papers receiving 1.6k citations

Hit Papers

Pharmacophore perception, development, and use in drug de... 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osman Güner United States 17 875 785 429 197 151 36 1.6k
Giovanna Tedesco Italy 12 1.1k 1.2× 891 1.1× 386 0.9× 171 0.9× 97 0.6× 15 1.6k
Simon F. Semus United States 11 1.3k 1.5× 1.1k 1.3× 367 0.9× 264 1.3× 116 0.8× 17 1.9k
Brian Y. Feng United States 11 1.2k 1.4× 599 0.8× 322 0.8× 212 1.1× 138 0.9× 18 1.9k
Jean‐François Truchon Canada 12 862 1.0× 756 1.0× 323 0.8× 178 0.9× 103 0.7× 19 1.4k
Thompson N. Doman United States 12 831 0.9× 501 0.6× 345 0.8× 117 0.6× 249 1.6× 24 1.5k
Brian Springthorpe United Kingdom 5 879 1.0× 589 0.8× 546 1.3× 179 0.9× 188 1.2× 8 1.8k
Stefan Senger United Kingdom 15 1.1k 1.2× 969 1.2× 373 0.9× 175 0.9× 88 0.6× 28 1.9k
Brian Clarke United Kingdom 3 933 1.1× 862 1.1× 264 0.6× 160 0.8× 92 0.6× 7 1.4k
Robin A. E. Carr United Kingdom 16 1.7k 2.0× 594 0.8× 624 1.5× 205 1.0× 178 1.2× 26 2.3k
Wolfgang Guba Switzerland 26 1.2k 1.4× 646 0.8× 504 1.2× 322 1.6× 175 1.2× 60 2.0k

Countries citing papers authored by Osman Güner

Since Specialization
Citations

This map shows the geographic impact of Osman Güner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osman Güner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osman Güner more than expected).

Fields of papers citing papers by Osman Güner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osman Güner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osman Güner. The network helps show where Osman Güner may publish in the future.

Co-authorship network of co-authors of Osman Güner

This figure shows the co-authorship network connecting the top 25 collaborators of Osman Güner. A scholar is included among the top collaborators of Osman Güner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osman Güner. Osman Güner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Güner, Osman, et al.. (2020). Akt Pathway Inhibitors. Current Topics in Medicinal Chemistry. 20(10). 883–900. 76 indexed citations
2.
Murnane, Kevin S., Osman Güner, J. Phillip Bowen, et al.. (2019). The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo. Pharmacology Biochemistry and Behavior. 181. 37–45. 10 indexed citations
3.
Güner, Osman, et al.. (2019). Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine. Anticancer Research. 39(10). 5329–5338. 9 indexed citations
4.
Güner, Osman, et al.. (2018). Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(19). 3247–3250. 4 indexed citations
5.
Xu, Qian, Amol A. Kulkarni, Ayyiliath M. Sajith, et al.. (2017). Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4. Bioorganic & Medicinal Chemistry. 26(5). 989–998. 22 indexed citations
6.
Güner, Osman & Jonathan P. Bowen. (2013). Pharmacophore Modeling for ADME. Current Topics in Medicinal Chemistry. 13(11). 1327–1342. 23 indexed citations
7.
Bowen, J. Phillip & Osman Güner. (2013). A Perspective on Quantum Mechanics Calculations in ADMET Predictions. Current Topics in Medicinal Chemistry. 13(11). 1257–1272. 8 indexed citations
8.
Güner, Osman. (2005). The impact of pharmacophore modeling in drug design.. PubMed. 8(7). 567–72. 19 indexed citations
9.
Güner, Osman. (2004). Ricâl Tenkidi Sisteminin Temel Karakteristiği ve Aktüel Değeri. DergiPark (Istanbul University). 1 indexed citations
10.
Güner, Osman, Omoshile Clement, & Yasuhisa Kurogi. (2004). Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances. Current Medicinal Chemistry. 11(22). 2991–3005. 128 indexed citations
11.
Vaschetto, M., et al.. (2003). Enabling high-throughput discovery.. PubMed. 6(3). 377–83. 7 indexed citations
12.
Güner, Osman. (2002). History and Evolution of the Pharmacophore Concept in Computer-Aided Drug Design. Current Topics in Medicinal Chemistry. 2(12). 1321–1332. 120 indexed citations
13.
Güner, Osman, et al.. (2002). Seeking novel leads through structure-based pharmacophore design. Journal of the Brazilian Chemical Society. 13(6). 777–787. 11 indexed citations
14.
Kurogi, Yasuhisa & Osman Güner. (2001). Pharmacophore Modeling and Three-dimensional Database Searching for Drug Design Using Catalyst. Current Medicinal Chemistry. 8(9). 1035–1055. 290 indexed citations
15.
Güner, Osman. (2000). Pharmacophore perception, development, and use in drug design. Medical Entomology and Zoology. 546 indexed citations breakdown →
16.
Güner, Osman, et al.. (1991). An integrated approach to three-dimensional information management with MACCS-3D. Journal of Chemical Information and Computer Sciences. 31(3). 408–414. 21 indexed citations
17.
Güner, Osman & Koop Lammertsma. (1990). Structural and electronic properties of the tetraatomic diberyllium diboride B2Be2 cluster. Journal of the American Chemical Society. 112(2). 508–516. 4 indexed citations
18.
Güner, Osman, Koop Lammertsma, Peter V. Alston, Raphael M. Ottenbrite, & Donald D. Shillady. (1990). Theoretical evaluation of epimerization in Diels-Alder cycloadducts. The Journal of Organic Chemistry. 55(1). 28–33. 7 indexed citations
19.
Lammertsma, Koop & Osman Güner. (1988). Structures and energies of disilicon dicarbide, C2Si2. Journal of the American Chemical Society. 110(16). 5239–5245. 50 indexed citations
20.
Güner, Osman, Raphael M. Ottenbrite, Donald D. Shillady, & Peter V. Alston. (1988). Epimerization and stereoselectivity in the Diels-Alder reaction of monosubstituted dienophiles. The Journal of Organic Chemistry. 53(22). 5348–5351. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026